Mint Medical and Agfa HealthCare announce seamless integration of mint Lesion and ORBIS RIS at RSNA 2018

Heidelberg, Bonn, GER - At this year’s Radiological Society of North America (RSNA) Annual Meeting 2018, Agfa HealthCare and Mint Medical will announce a seamless integration of ORBIS RIS and mint Lesion™ - a platform for structured image-based reporting. This integration is a major improvement of the interaction of both systems for joint customers, especially for the use in clinical routine. Users are now able to open mint Lesion™ directly from the ORBIS RIS reporting within the same patient and user context. After completion of the reading and reporting in mint Lesion™, the results are automatically integrated into the ORBIS RIS report.

„An efficient radiological assessment, with the assistance of modern IT systems, is crucial for user satisfaction. The better involved systems interact, the more comfortable the user experience, and we are pleased to be able to offer this to our customers,” states Dr. Matthias Baumhauer, CEO, Mint Medical GmbH.

Winfried Post, General Manager and Managing Director, Agfa HealthCare DACH, explains: „With the integration of mint Lesion™ with ORBIS RIS we respond to the great wish of our joint customers for a convincing interaction of both systems. We are convinced that the future belongs to those systems that open up and, in the interest of our customers, can be well integrated into each other.”

Existing as well as new customers can order the integration solution directly from Mint Medical, and its implementation is realized in close coordination with the Agfa HealthCare team.

mint Lesion™ allows for multi-modality reading and reporting while at the same time considering the concrete reading task as well as the relevant guideline and automatically creates a structured report. The software guides the user through the reading process ensuring all relevant pieces of information are captured and are therefore conform with e.g. the ACR RADS classification, the TNM criteria or therapy response criteria like RECIST 1.1.

ORBIS RIS is one of the leading RIS in the German-speaking countries and is used by more than 400 customers.

 

About Mint Medical:

Mint Medical GmbH located in Heidelberg/Germany was founded in 2010 as a spin-off of German Cancer Research Center. The company commits itself to developing innovative software solutions in the field of medical imaging and combines image assessment and reporting in one system by considering guidelines for each clinical application context. A particular focus is currently being set on the field of oncology where the software mint Lesion is applied in clinical routine and clinical trials. Customers of Mint Medical are radiological practices, (university) hospitals, cancer centers and (Imaging) CROs all over the world. In addition to the headquarters in Germany, the company has a subsidiary, Mint Medical Inc., in New Jersey, USA.

About Agfa HealthCare:

Agfa HealthCare is a leading provider of IT-based healthcare solutions for the use in hospitals and healthcare institutions all over the world. Furthermore, Agfa HealthCare is one of the leading providers of healthcare information systems for the integration of clinical, administrative and financially relevant workflows of single hospitals and hospital groups.

Related Resources

Related Resources

RECIST measurements of a patient with uveal melanoma and hepatic metastases

University Hospital Tuebingen: Study compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study[1] conducted by researchers at University Hospital Tuebingen retrospectively compared the efficacy of two liver-targeted therapies,…

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…

A picture of a person looking at a brain scan and the interface of mint Lesion™  on a computer

Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™

Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…